Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ROME -- Edoxaban ...
Warfarin, dabigatran and rivaroxaban are safe periprocedural anticoagulation options for patients undergoing cardioversion or ablation for atrial fibrillation, according to researchers in Canada. “We ...
"Providing adequate anticoagulation therapy for patients with AF undergoing cardio-version is important. With warfarin, patients will often move in and out of the therapeutic range for optimal ...
September 22, 2003 — Further investigation aimed at improving efficacy and safety of anticoagulant treatment prior to direct current cardioversion (DCC) for restoration of atrial fibrillation (AF) is ...
Low-molecular-weight heparins such as enoxaparin have shown benefit in MI and unstable angina and have been more effective in preventing venous thrombosis than unfractionated heparin. The latter is, ...
Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with atrial fibrillation scheduled for elective cardioversion, according to new research. Apixaban lowers the ...
Patients with atrial fibrillation (AF) who need anticoagulation before undergoing electrical correction of their abnormal heartbeat (cardioversion) may benefit from treatment with edoxoban - a ...
Cardioversion can improve heart function, reduce the risk of embolism and relieve symptoms in patients with atrial fibrillation. Despite anticoagulation therapy, thromboembolic complications can still ...
This press release accompanies both a presentation and an ESC press conference at the ESC Congress 2016. Edited by the ESC from material supplied by the investigators themselves, this press release ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback